BIT 2.70% 3.8¢ biotron limited

These preliminary, positive trial data are very encouraging. The...

  1. 2,845 Posts.
    lightbulb Created with Sketch. 285
    These preliminary, positive trial data are very encouraging. The blood viral load reduction data are consistent with BIT225 having an impact on viral reservoirs. Current cART is efficient at rapidly and durably reducing virus levels in the blood, but this does not translate into clearance of long-lived reservoirs of HIV-1. “. “The observed changes to immune markers and cells further the results from the previous BIT225-009 trial and SUGGESTS the utility of targeting VIROPORINS as a NEW CLASS of ANTIVIRAL DRUGS
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
0.001(2.70%)
Mkt cap ! $34.28M
Open High Low Value Volume
3.7¢ 4.0¢ 3.7¢ $27.9K 723.0K

Buyers (Bids)

No. Vol. Price($)
1 511254 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 99951 1
View Market Depth
Last trade - 12.22pm 28/06/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.